医療用プラスチックコンパウンドの世界市場：製品別、用途別、地域別の分析、規模、動向、COVID-19の影響、予測（～2029年）

世界の医療用プラスチックコンパウンドの市場規模は、2023年に635億6,000万米ドルでした。2029年までに834億4,000万米ドルに達すると予測されています。医療用プラスチックコンパウンドは、ベースとなる医療用プラスチックに、可塑剤、安定剤、充填剤、着色剤、抗菌剤などのさまざまな添加剤を組み合わせて作られる製剤です。これらのコンパウンドは、柔軟性、強度、耐薬品性、滅菌適合性の向上など、医療用途における特定の性能要件を満たすために、ベースプラスチックの特性を強化するように設計されています。

今後数年間、医療用プラスチックコンパウンド市場は、複数の動向の集中により成長を続けると予測されます。主な要因の1つは、世界の老年人口の増加です。高齢者は通常、より多くの医療製品や医療機器を必要とするため、医療用途において、耐久性がありコスト効率と生体適合性の高いプラスチック材料の需要が高まっています。さらに、材料配合の進歩や継続的な技術革新も医療用プラスチックコンパウンド市場の成長に寄与しています。新しい材料や製造技法により、医療用プラスチック製品の性能、コスト効率、持続可能性が向上しています。さらに、医療費の増加と医療インフラの強化に向けた政府の取り組みの増加が、市場の拡大を支えると予測されます。継続的な技術の進歩と世界的な医療ニーズの高まりにより、医療用プラスチックコンパウンド市場は今後数年で大きく成長する見通しです。市場は2024年～2029年の予測期間にCAGRで約5%の成長が見込まれます。

当レポートでは、世界の医療用プラスチックコンパウンド市場について調査分析し、市場力学、COVID-19の影響、競合情勢などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

• 医療用プラスチックコンパウンド：概要
  • 医療用プラスチックコンパウンドのイントロダクション
  • 医療用プラスチックコンパウンドの主な種類
• 医療用プラスチックコンパウンドのセグメンテーション：概要
  • 医療用プラスチックコンパウンドのセグメンテーション

第3章 世界市場の分析

• 世界の医療用プラスチックコンパウンド市場：分析
  • 世界の医療用プラスチックコンパウンド市場：概要
  • 世界の医療用プラスチックコンパウンドの市場規模
  • 世界の医療用プラスチックコンパウンド市場：製品別
  • 世界の医療用プラスチックコンパウンド市場：用途別
  • 世界の医療用プラスチックコンパウンド市場：地域別
• 世界の医療用プラスチックコンパウンド市場：製品の分析
  • 世界の医療用プラスチックコンパウンド市場：製品別、概要
  • 世界のポリ塩化ビニル（PVC）医療用プラスチックコンパウンドの市場規模
  • 世界のポリエチレン医療用プラスチックコンパウンドの市場規模
  • 世界のポリプロピレン医療用プラスチックコンパウンドの市場規模
  • 世界のポリスチレン医療用プラスチックコンパウンドの市場規模
  • 世界のポリカーボネート医療用プラスチックコンパウンドの市場規模
  • 世界のポリエステル医療用プラスチックコンパウンドの市場規模
  • 世界のポリウレタン医療用プラスチックコンパウンドの市場規模
  • 世界のアクリル医療用プラスチックコンパウンドの市場規模
  • 世界のその他の医療用プラスチックコンパウンドの市場規模
• 世界の医療用プラスチックコンパウンド市場：用途の分析
  • 世界の医療用プラスチックコンパウンド市場：用途別、概要
  • 世界の医療用プラスチックコンパウンド使い捨て用品の市場規模
  • 世界の医療用プラスチックコンパウンドドラッグデリバリーシステムの市場規模
  • 世界の医療用プラスチックコンパウンドインプラントの市場規模
  • 世界の医療用プラスチックコンパウンド手術器具の市場規模
  • 世界の医療用プラスチックコンパウンド医療用バッグの市場規模
  • 世界の医療用プラスチックコンパウンドカテーテルの市場規模
  • 世界のその他の医療用プラスチックコンパウンドの市場規模

第4章 地域市場の分析

• 北米の医療用プラスチックコンパウンド市場：分析
  • 北米の医療用プラスチックコンパウンド市場：概要
  • 北米の医療用プラスチックコンパウンドの市場規模
  • 北米の医療用プラスチックコンパウンド市場：製品別
  • 北米の医療用プラスチックコンパウンド製品の市場規模
  • 北米の医療用プラスチックコンパウンド市場：地域別
  • 米国の医療用プラスチックコンパウンドの市場規模
  • カナダの医療用プラスチックコンパウンドの市場規模
  • メキシコの医療用プラスチックコンパウンドの市場規模
• 欧州の医療用プラスチックコンパウンド市場：分析
  • 欧州の医療用プラスチックコンパウンド市場：概要
  • 欧州の医療用プラスチックコンパウンドの市場規模
  • 欧州の医療用プラスチックコンパウンド市場：製品別
  • 欧州の医療用プラスチックコンパウンド製品の市場規模
  • 欧州の医療用プラスチックコンパウンド市場：用途別
  • 欧州の医療用プラスチックコンパウンド用途の市場規模
  • 欧州の医療用プラスチックコンパウンド市場：地域別
  • ドイツの医療用プラスチックコンパウンドの市場規模
  • 英国の医療用プラスチックコンパウンドの市場規模
  • フランスの医療用プラスチックコンパウンドの市場規模
  • スペインの医療用プラスチックコンパウンドの市場規模
  • イタリアの医療用プラスチックコンパウンドの市場規模
  • その他の欧州の医療用プラスチックコンパウンドの市場規模
• アジア太平洋の医療用プラスチックコンパウンド市場：分析
  • アジア太平洋の医療用プラスチックコンパウンド市場：概要
  • アジア太平洋の医療用プラスチックコンパウンドの市場規模
  • アジア太平洋の医療用プラスチックコンパウンド市場：地域別
  • 中国の医療用プラスチックコンパウンドの市場規模
  • 日本の医療用プラスチックコンパウンドの市場規模
  • 韓国の医療用プラスチックコンパウンドの市場規模
  • インドの医療用プラスチックコンパウンドの市場規模
  • その他のアジア太平洋の医療用プラスチックコンパウンドの市場規模
• その他の地域の医療用プラスチックコンパウンド市場：分析
  • その他の地域の医療用プラスチックコンパウンド市場：概要
  • その他の地域の医療用プラスチックコンパウンドの市場規模

第5章 COVID-19の影響

• 医療用プラスチックコンパウンド市場に対するCOVID-19の影響
• 医療用プラスチックコンパウンド市場に対するCOVID-19後の影響

第6章 市場力学

• 成長促進要因
  • 高齢化
  • 医療費の増加
  • 慢性疾患の増加
  • 使い捨て医療用品へのシフトの進行
  • 政府の取り組みと規制
  • 医療技術の進歩
• 課題
  • プラスチック廃棄物の環境に対する影響
  • 可塑剤と浸出物に関する懸念
• 市場動向
  • 医療機器産業の拡大
  • メディカルツーリズムの急増
  • 医療用プラスチックコンパウンドの経済的利点
  • 抗菌性、滅菌耐性医療用プラスチックコンパウンド
  • 研究開発への多額の投資

第7章 競合情勢

• 世界の医療用プラスチックコンパウンド市場：近年の動向

第8章 企業プロファイル

• BASF SE
• Compagnie de Saint-Gobain S.A.
• DuPont de Nemours, Inc.
• Dow Inc. (The Dow Chemical Company)
• Celanese Corporation
• Covestro AG
• Eastman Chemical Company
• SABIC (Saudi Basic Industries Corporation)
• Evonik Industries AG
• Nolato AB
• Solvay SA
• Rochling Group
• Orthoplastics Limited

List of Tables

• Table 1: Global Medical Plastic Compounds Market: Recent Developments & Product Offerings

List of Figures

• Figure 1: Medical plastic compounds Segmentation
• Figure 1: Major Types of Medical Plastic Compounds
• Figure 2: Medical Plastic Compounds Segmentation
• Figure 3: Global Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 4: Global Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 5: Global Medical Plastic Compounds Market by Product; 2023 (Percentage, %)
• Figure 6: Global Medical Plastic Compounds Market by Application; 2023 (Percentage, %)
• Figure 7: Global Medical Plastic Compounds Market by Region; 2023 (Percentage, %)
• Figure 8: Global Polyvinyl Chloride (PVC) Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 9: Global Polyvinyl Chloride (PVC) Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 10: Global Polyethylene Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 11: Global Polyethylene Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 12: Global Polypropylene Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 13: Global Polypropylene Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 14: Global Polystyrene Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 15: Global Polystyrene Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 16: Global Polycarbonate Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 17: Global Polycarbonate Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 18: Global Polyester Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 19: Global Polyester Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 20: Global Polyurethane Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 21: Global Polyurethane Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 22: Global Acrylics Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 23: Global Acrylics Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 24: Global Others Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 25: Global Others Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 26: Global Medical Plastic Compounds Disposables Market by Value; 2019-2023 (US$ Billion)
• Figure 27: Global Medical Plastic Compounds Disposables Market by Value; 2019-2023 (US$ Billion)
• Figure 28: Global Medical Plastic Compounds Drug Delivery System Market by Value; 2019-2023 (US$ Billion)
• Figure 29: Global Medical Plastic Compounds Drug Delivery System Market by Value; 2024-2029 (US$ Billion)
• Figure 30: Global Medical Plastic Compounds Implants Market by Value; 2019-2023 (US$ Billion)
• Figure 31: Global Medical Plastic Compounds Implants Market by Value; 2024-2029 (US$ Billion)
• Figure 32: Global Medical Plastic Compounds Surgical Instruments Market by Value; 2019-2023 (US$ Billion)
• Figure 33: Global Medical Plastic Compounds Surgical Instruments Market by Value; 2024-2029 (US$ Billion)
• Figure 34: Global Medical Plastic Compounds Medical Bags Market by Value; 2019-2023 (US$ Billion)
• Figure 35: Global Medical Plastic Compounds Medical Bags Market by Value; 2024-2029 (US$ Billion)
• Figure 36: Global Medical Plastic Compounds Catheters Market by Value; 2019-2023 (US$ Billion)
• Figure 37: Global Medical Plastic Compounds Catheters Market by Value; 2024-2029 (US$ Billion)
• Figure 38: Global Others Medical Plastic Compounds Market by Value; 2019-2023 (US$ Million)
• Figure 39: Global Others Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 40: North America Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 41: North America Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 42: North America Medical Plastic Compounds Market by Product; 2023 (Percentage, %)
• Figure 43: North America Medical Plastic Compounds Product Market by Value; 2023-2029 (US$ Billion)
• Figure 44: North America Medical Plastic Compounds Market by Region; 2023 (Percentage%)
• Figure 45: The US Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 46: The US Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 47: Canada Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 48: Canada Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 49: Mexico Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 50: Mexico Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 51: Europe Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 52: Europe Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 53: Europe Medical Plastic Compounds Market by Product; 2023 (Percentage, %)
• Figure 54: Europe Medical Plastic Compounds Product Market by Value; 2023-2029 (US$ Billion)
• Figure 55: Europe Medical Plastic Compounds Market by Application; 2023 (Percentage, %)
• Figure 56: Europe Medical Plastic Compounds Application Market by Value; 2023-2029 (US$ Billion)
• Figure 57: Europe Medical Plastic Compounds Market by Region; 2023 (Percentage, %)
• Figure 58: Germany Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 59: Germany Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 60: UK Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 61: UK Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 62: France Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 63: France Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 64: Spain Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 65: Spain Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 66: Italy Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 67: Italy Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 68: Rest of Europe Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 69: Rest of Europe Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 70: Asia Pacific Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 71: Asia Pacific Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 72: Asia Pacific Medical Plastic Compounds Market by Region; 2023 (Percentage%)
• Figure 73: China Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 74: China Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 75: Japan Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 76: Japan Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 77: South Korea Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 78: South Korea Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 79: India Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 80: India Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 81: Rest of Asia Pacific Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 82: Rest of Asia Pacific Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 83: Rest of the World Medical Plastic Compounds Market by Value; 2019-2023 (US$ Billion)
• Figure 84: Rest of the World Medical Plastic Compounds Market by Value; 2024-2029 (US$ Billion)
• Figure 85: Global Population Aged 65 Years Or Over; 2018-2023 (Million)
• Figure 86: Global Health Expenditure as a Percentage of GDP; 2016-2023 (Percentage, %)
• Figure 87: Global Number of People with Diabetes (20-79 years); 2000-2045 (Million)
• Figure 88: Global Medical Devices Market Revenue for Different Segments; 2019-2026 (US$ Billion)
• Figure 89: Global Medical Tourism Market; 2024-2029 (US$ Billion)
• Figure 90: BASF SE Sales by Segments; 2023 (Percentage, %)
• Figure 91: Compagnie de Saint-Gobain S.A. Sales by Segment; 2023 (Percentage, %)
• Figure 92: DuPont de Nemours, Inc. Net Sales by Segments, 2023 (Percentage, %)
• Figure 93: Dow Inc. Net Sales by Segments; 2023 (Percentage,%)
• Figure 94: Celanese Corporation Net Sales by Segment; 2023 (Percentage, %)
• Figure 95: Covestro Net Sales by Operating Segments; 2023 (Percentage, %)
• Figure 96: Eastman Chemical Company Sales by Operating Segments; 2023 (Percentage, %)
• Figure 97: SABIC Revenue by Businesses; 2023 (Percentage %)
• Figure 98: Evonik Industries AG Sales by Segment; 2023 (Percentage, %)
• Figure 99: Nolato AB Net Sales by Operating Segments; 2023 (Percentage, %)
• Figure 100: Solvay SA Net Sales by Segment; 2023 (Percentage, %)

The global medical plastic compounds market was valued at US$63.56 billion in 2023. The market value is expected to reach US$83.44 billion by 2029. Medical plastic compounds are the formulations made by combining a base medical plastic with various additives, such as plasticizers, stabilizers, fillers, colorants, or antimicrobial agents. These compounds are designed to enhance the properties of the base plastic to meet specific performance requirements in medical applications, such as increased flexibility, strength, chemical resistance, or sterilization compatibility.

In the forthcoming years, the medical plastic compounds market is expected to continue growing due to several converging trends. One key factor is the increasing global aging population, as older adults typically require more healthcare products and medical devices, driving demand for durable, cost-effective, and biocompatible plastic materials in medical applications. Furthermore, advancements in material formulations and ongoing innovation are also contributing to the growth of the medical plastic compounds market. New materials and manufacturing techniques are improving the performance, cost-efficiency, and sustainability of medical plastic products. Additionally, rising healthcare expenditure and increased government initiatives to strengthen healthcare infrastructure are expected to support the market's expansion. With continuous technological advancements and increasing global healthcare needs, the market for medical plastic compounds is poised for significant growth in the coming years. The market is expected to grow at a CAGR of approx. 5% during the forecasted period of 2024-2029.

Market Segmentation Analysis:

By Product: Based on product, the market can be bifurcated into nine segments: Polyvinylchloride, Polyethylene, Polypropylene, Polystyrene, Polycarbonate, Polyester, Polyurethane, Acrylics, and Others. The polyvinylchloride segment held a significant share of the global medical plastic compounds market. The growth of the PVC segment has been driven by the increasing demand for disposable medical products as healthcare systems prioritize hygiene, safety, and cost-effectiveness. The rising focus on cost-effective healthcare solutions, alongside PVC's ability to be easily processed and its versatility in different applications, further boosts its demand. In the future, the market for PVC is expected to expand due to growing healthcare needs, the aging population, and advancements in medical device technologies. Moreover, there is a shift towards more sustainable, non-toxic PVC formulations, which is likely to likely enhance its appeal in the market, aligning with the global trend toward environmentally friendly solutions in healthcare.

By Application: The report provides the split of global medical plastic compounds market in terms of application: Disposables, Drug Delivery System, Implants, Surgical Instruments, Medical Bags, Catheters, and Others. The disposables segment holds a significant share of the global medical plastic compounds market. The expansion of this segment has been driven by increasing concerns about infection control, especially after the COVID-19 pandemic, where disposable products were crucial in reducing cross-contamination. Additionally, disposables are cost-effective, eliminating the need for sterilization and reducing the risk of healthcare-associated infections. Moving forward, factors such as rising healthcare standards, increasing surgical and diagnostic procedures, and growing global health awareness, particularly in emerging markets, are expected to continue propelling growth in this segment.

By Region: In the report, the global medical plastic compounds market is divided into four regions: North America (The US, Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia Pacific (China, Japan, South Korea, India, and rest of Asia Pacific), and Rest of the World. In 2023, the North America region led the medical plastic compounds market, propelled by several key factors, including increasing demand for medical devices, advancements in healthcare technologies, and the need for cost-effective solutions in the medical industry. The region benefits from a robust healthcare infrastructure, home to numerous leading medical device manufacturers and research institutions.

During 2024-2029, the US is forecasted to maintain its lead within North America, with its well-established healthcare infrastructure, which includes hospitals, medical device manufacturers, and diagnostic centers, all requiring high-performance medical plastics. Strict regulatory frameworks such as the FDA's guidelines on medical devices and materials drive demand for safe and durable plastic compounds. Moreover, advancements in plastic formulations have enabled the development of specialized compounds for critical applications like drug delivery systems, implants, and surgical instruments.

Market Dynamics:

Growth Drivers: The global medical plastic compounds market growth is predicted to be supported by numerous growth drivers such as aging population, rise in healthcare expenditure, increasing prevalence of chronic diseases, Advances in medical technology, and many other factors. The shift toward disposable medical products has significantly contributed to the growth of the medical plastic compounds market. This trend is primarily driven by heightened concerns regarding hygiene, safety, and cost-efficiency in healthcare settings. As the demand for cost-effective and hygienic medical solutions grows globally, especially in response to the ongoing concerns around healthcare-associated infections, the need for disposable products continues to rise, driving the increased demand for medical plastic compounds. This trend also supports the market's expansion as manufacturers look to develop innovative and sustainable materials that meet the evolving needs of the healthcare industry.

Challenges: However, the market growth would be negatively impacted by various challenges such as environmental impact of plastic waste, concerns over plasticizers and leachable, etc.

Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as expansion of the medical device industry, economic advantage of medical plastic compounds, surging trend of medical tourism, large investments in research and development, etc. Medical plastic compounds that are resistant to sterilization processes like autoclaving, radiation, and chemical sterilants are essential for maintaining the integrity and performance of devices over time. These advanced plastic materials are particularly important in environments where hygiene and sterility are paramount, such as hospitals, clinics, and surgical centers. As awareness of healthcare-associated infections (HAIs) increases and the demand for sterile medical products rises, manufacturers are increasingly turning to antimicrobial and sterilization-resistant medical plastic compounds to meet these needs. This trend not only helps reduce the risk of infections but also extends the lifespan of medical devices, making them a highly attractive choice for healthcare providers. The growing demand for such advanced materials is thus propelling the market growth of these compounds, as they offer enhanced safety, durability, and long-term performance in medical applications.

Impact Analysis of COVID-19 and Way Forward:

The COVID-19 pandemic significantly disrupted the global medical plastic compounds market, causing supply chain interruptions, production delays, and a decline in demand from critical sectors like healthcare, medical devices, and pharmaceuticals due to economic instability and uncertainty. Lockdowns and restrictions on movement led to labor shortages, delays in raw material availability, and temporary shutdowns of manufacturing facilities, all of which hampered market growth. However, the post-pandemic period presents an opportunity for recovery, driven by the increased demand for medical devices, healthcare solutions, and personal protective equipment (PPE), as well as a rising focus on hygiene and health. Innovations in biocompatible and sustainable medical plastics, alongside advancements in recycling technologies and increased emphasis on eco-friendly materials, are expected to drive market expansion. As healthcare systems adapt to new requirements and consumer preferences shift toward more sustainable and safe products, the global medical plastic compounds market is on track for a steady recovery with a focus on more resilient and environmentally responsible production practices.

Competitive Landscape:

The global medical plastic compounds market is highly competitive, featuring a blend of large multinational players and regional companies that focus on producing high-quality medical-grade plastic materials that meet stringent safety and regulatory standards. The key players in the global medical plastic compounds market are:

BASF SE

Compagnie de Saint-Gobain S.A.

DuPont de Nemours, Inc.

Dow Inc.

Celanese Corporation

Covestro AG

Eastman Chemical Company

SABIC (Saudi Basic Industries Corporation)

Evonik Industries AG

Nolato AB

Solvay SA

Rochling Group

Orthoplastics Limited

Table of Contents

1. Executive Summary

2. Introduction

• 2.1 Medical Plastic Compounds: An Overview
  • 2.1.1 Introduction to Medical Plastic Compounds
  • 2.1.2 Major Types of Medical Plastic Compounds
• 2.2 Medical Plastic Compounds Segmentation: An Overview
  • 2.2.1 Medical Plastic Compounds Segmentation

3. Global Market Analysis

• 3.1 Global Medical Plastic Compounds Market: An Analysis
  • 3.1.1 Global Medical Plastic Compounds Market: An Overview
  • 3.1.2 Global Medical Plastic Compounds Market by Value
  • 3.1.3 Global Medical Plastic Compounds Market by Product
  • 3.1.4 Global Medical Plastic Compounds Market by Application
  • 3.1.5 Global Medical Plastic Compounds Market by Region
• 3.2 Global Medical Plastic Compounds Market: Product Analysis
  • 3.2.1 Global Medical Plastic Compounds Market By Product: An Overview
  • 3.2.2 Global Polyvinyl Chloride (PVC) Medical Plastic Compounds Market By Value
  • 3.2.3 Global Polyethylene Medical Plastic Compounds Market By Value
  • 3.2.4 Global Polypropylene Medical Plastic Compounds Market By Value
  • 3.2.5 Global Polystyrene Medical Plastic Compounds Market By Value
  • 3.2.6 Global Polycarbonate Medical Plastic Compounds Market By Value
  • 3.2.7 Global Polyester Medical Plastic Compounds Market By Value
  • 3.2.8 Global Polyurethane Medical Plastic Compounds Market By Value
  • 3.2.9 Global Acrylics Medical Plastic Compounds Market By Value
  • 3.2.10 Global Others Medical Plastic Compounds Market By Value
• 3.3 Global Medical Plastic Compounds Market: Application Analysis
  • 3.3.1 Global Medical Plastic Compounds Market By Application: An Overview
  • 3.3.2 Global Medical Plastic Compounds Disposables Market By Value
  • 3.3.3 Global Medical Plastic Compounds Drug Delivery System Market By Value
  • 3.3.4 Global Medical Plastic Compounds Implants Market By Value
  • 3.3.5 Global Medical Plastic Compounds Surgical Instruments Market By Value
  • 3.3.6 Global Medical Plastic Compounds Medical Bags Market By Value
  • 3.3.7 Global Medical Plastic Compounds Catheters Market By Value
  • 3.3.8 Global Others Medical Plastic Compounds Market By Value

4. Regional Market Analysis

• 4.1 North America Medical Plastic Compounds Market: An Analysis
  • 4.1.1 North America Medical Plastic Compounds Market: An Overview
  • 4.1.2 North America Medical Plastic Compounds Market by Value
  • 4.1.3 North America Medical Plastic Compounds Market by Product
  • 4.1.4 North America Medical Plastic Compounds Product Market by Value
  • 4.1.5 North America Medical Plastic Compounds Market by Region
  • 4.1.6 The US Medical Plastic Compounds Market by Value
  • 4.1.7 Canada Medical Plastic Compounds Market by Value
  • 4.1.8 Mexico Medical Plastic Compounds Market by Value
• 4.2 Europe Medical Plastic Compounds Market: An Analysis
  • 4.2.1 Europe Medical Plastic Compounds Market: An Overview
  • 4.2.2 Europe Medical Plastic Compounds Market by Value
  • 4.2.3 Europe Medical Plastic Compounds Market by Product
  • 4.2.4 Europe Medical Plastic Compounds Product Market by Value
  • 4.2.5 Europe Medical Plastic Compounds Market by Application
  • 4.2.6 Europe Medical Plastic Compounds Application Market by Value
  • 4.2.7 Europe Medical Plastic Compounds Market by Region
  • 4.2.8 Germany Medical Plastic Compounds Market by Value
  • 4.2.9 UK Medical Plastic Compounds Market by Value
  • 4.2.10 France Medical Plastic Compounds Market by Value

4.2.11Spain Medical Plastic Compounds Market by Value

4.2.12Italy Medical Plastic Compounds Market by Value

• 4.2.13 Rest of Europe Medical Plastic Compounds Market by Value
• 4.3 Asia Pacific Medical Plastic Compounds Market: An Analysis
  • 4.3.1 Asia Pacific Medical Plastic Compounds Market: An Overview
  • 4.3.2 Asia Pacific Medical Plastic Compounds Market by Value
  • 4.3.3 Asia Pacific Medical Plastic Compounds Market by Region
  • 4.3.4 China Medical Plastic Compounds Market by Value
  • 4.3.5 Japan Medical Plastic Compounds Market by Value
  • 4.3.6 South Korea Medical Plastic Compounds Market by Value
  • 4.3.7 India Medical Plastic Compounds Market by Value
  • 4.3.8 Rest of Asia Pacific Medical Plastic Compounds Market by Value
• 4.4 Rest of the World Medical Plastic Compounds Market: An Analysis
  • 4.4.1 Rest of the World Medical Plastic Compounds Market: An Overview
  • 4.4.2 Rest of the World Medical Plastic Compounds Market by Value

5. Impact of COVID-19

• 5.1 Impact of COVID-19 on Medical Plastic Compounds Market
• 5.2 Post COVID-19 Impact on Medical Plastic Compounds Market

6. Market Dynamics

• 6.1 Growth Drivers
  • 6.1.1 Aging Population
  • 6.1.2 Rise in Healthcare Expenditure
  • 6.1.3 Increasing Prevalence of Chronic Diseases
  • 6.1.4 Rising Shift Toward Disposable Medical Products
  • 6.1.5 Government Initiatives and Regulations
  • 6.1.6 Advances in Medical Technology
• 6.2 Challenges
  • 6.2.1 Environmental Impact of Plastic Waste
  • 6.2.2 Concerns Over Plasticizers and Leachable
• 6.3 Market Trends
  • 6.3.1 Expansion of the Medical Device Industry
  • 6.3.2 Surging Trend of Medical Tourism
  • 6.3.3 Economic Advantage of Medical Plastic Compounds
  • 6.3.4 Antimicrobial and Sterilization-Resistant Medical Plastic Compounds
  • 6.3.5 Large Investments in Research and Development

7. Competitive Landscape

• 7.1 Global Medical Plastic Compounds Market: Recent Developments

8. Company Profiles

• 8.1 BASF SE
  • 8.1.1 Business Overview
  • 8.1.2 Operating Segments
  • 8.1.3 Business Strategy
• 8.2 Compagnie de Saint-Gobain S.A.
  • 8.2.1 Business Overview
  • 8.2.2 Operating Segments
  • 8.2.3 Business Strategy
• 8.3 DuPont de Nemours, Inc.
  • 8.3.1 Business Overview
  • 8.3.2 Operating Segments
  • 8.3.3 Business Strategy
• 8.4 Dow Inc. (The Dow Chemical Company)
  • 8.4.1 Business Overview
  • 8.4.2 Operating Segments
  • 8.4.3 Business Strategy
• 8.5 Celanese Corporation
  • 8.5.1 Business Overview
  • 8.5.2 Operating Segments
  • 8.5.3 Business Strategy
• 8.6 Covestro AG
  • 8.6.1 Business Overview
  • 8.6.2 Operating Segments
  • 8.6.3 Business Strategy
• 8.7 Eastman Chemical Company
  • 8.7.1 Business Overview
  • 8.7.2 Operating Segments
  • 8.7.3 Business Strategy
• 8.8 SABIC (Saudi Basic Industries Corporation)
  • 8.8.1 Business Overview
  • 8.8.2 Operating Segments
  • 8.8.3 Business Strategy
• 8.9 Evonik Industries AG
  • 8.9.1 Business Overview
  • 8.9.2 Operating Segments
  • 8.9.3 Business Strategy
• 8.10 Nolato AB
  • 8.10.1 Business Overview
  • 8.10.2 Operating Segments
  • 8.10.3 Business Strategy
• 8.11 Solvay SA
  • 8.11.1 Business Overview
  • 8.11.2 Operating Segments
  • 8.11.3 Business Strategy
• 8.12 Rochling Group
  • 8.12.1 Business Overview
  • 8.12.2 Business Strategy
• 8.13 Orthoplastics Limited
  • 8.13.1 Business Overview